MedTrace Logo

The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study

NCT02585258 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 451

Last updated 2023-07-18

Study results available
· View outcomes & findings →

Summary

Comparing the cost-effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis:

The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (GLORIA)

Conditions

Interventions

DRUG

Prednisolone

1 capsule containing a tablet of 5 mg prednisolone/ day

DRUG

Placebo

1 capsule containing a placebo tablet / day

Sponsors & Collaborators

Principal Investigators

  • Maarten Boers, Prof. dr. · Amsterdam UMC, location VUmc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Portugal
  • Romania
  • Slovakia

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02585258 on ClinicalTrials.gov